Stocks and Investing
by (remove) : Kelsey Goodwin
RSS • JSON • XML • CSV
Stocks and Investing
by (remove) : Kelsey Goodwin
RSS • JSON • XML • CSV

Kelsey Goodwin Initiated (URGN) at Strong Buy and Held Target at $40 on, Aug 22nd, 2024


Published on 2024-10-28 13:49:46 - WOPRAI, Kelsey Goodwin
  Print publication without navigation


Kelsey Goodwin of Guggenheim, Initiated "UroGen Pharma Ltd." (URGN) at Strong Buy and Held Target at $40 on, Aug 22nd, 2024.

Kelsey has made no other calls on URGN in the last 4 months.



There are 3 other peers that have a rating on URGN. Out of the 3 peers that are also analyzing URGN, 0 agree with Kelsey's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Kelsey

  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $60 on, Thursday, August 15th, 2024
  • Leland Gershell of "Oppenheimer" Maintained at Buy with Increased Target to $40 on, Friday, June 14th, 2024
  • Matthew Kaplan of "Ladenburg Thalmann" Maintained at Strong Buy with Increased Target to $54 on, Friday, June 14th, 2024
Contributing Sources